Senolytic therapy in mild Alzheimer’s disease: a phase 1 feasibility trialNature MedicineSeptember 7, 202310.1038/s41591-023-02543-wCited by 247SaveCiteExport RISWatch citationsRelated PapersNo related papers foundPowered by citation graph analysis